Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer
暂无分享,去创建一个
E. Scarpi | P. Caroli | V. Conteduca | U. de Giorgi | G. Schepisi | G. Gurioli | S. Salvi | F. Matteucci | V. Casadio | C. Lolli | S. Burgio | C. Menna | G. Paganelli | S. Testoni